LGALS9 and cancer: Notably, LDHC knockdown also resulted in lower levels of soluble Gal-9 in cancer cell monocultures and indirect co-cultures, which likely reduces its binding to the inhibitory immune checkpoint receptor TIM3, thereby enhancing T cell activation [45].